Skip to main content
. Author manuscript; available in PMC: 2024 Aug 29.
Published in final edited form as: Biochem Pharmacol. 2021 Sep 21;193:114781. doi: 10.1016/j.bcp.2021.114781

Table 1.

Averaged kinetic characteristics of the current traces evoked by sustained (4 min) applications of saturating agonist concentrations in oocytes expressing WT m5-HT3AR (100 μM 5-HT), WT ZAC (10 mM Zn2+), WT hα1 GlyR (100 μM Gly) and the chimeric receptors m5-HT3A/ZAC (3 μM 5-HT) and ZAC/hα1-Gly (30 μM Zn2+). Δtstart-to-peak: time from the start of the agonist application until peak current is reached (in s); Δtpeak-to-plateau (WT hα1 GlyR and ZAC/hα1-Gly): time from the peak current to plateau is reached (in s); Iresidual, 4 min: residual current after 4 min of agonist application (in % of peak current). Data are given as mean ± S.E.M. values with the number of traces (n) upon which the respective data are based. Representative traces are given in Fig. 2C and Fig. 3C.

Receptor Δtstart-to-peak (s) Δtpeak-to-plateau (s) Iresidual, 4 min
(% of Ipeak)
n
WT m5-HT3AR 2.1 ± 0.4 ~0 (none) 7
m5-HT3A/ZAC 46 ± 7.2 67 ± 6 5
WT ZAC 4.8 ± 0.5 21 ± 3 8
ZAC/hα1-Gly 10 ± 1.9 56 ± 3.8 63 ± 6 8
WT hα1 GlyR 2.7 ± 0.3 52 ± 5.9 51 ± 5 7